-
NSE
2,207.00 2,207.00(%) -
SBI
1,159.70 1,234.80(%) -
One 97
1,664.70 947.10(%) -
Billionbrains
218.00 142.05(%) -
LG Electronics
1,725.00 1,835.00(%) -
Bharat Forge
1,734.40 2,293.00(%) -
Maruti Suzuki
13,619.60 17,371.60(%) -
Reliance Industries
1,381.95 1,611.20(%) -
Samvardh. Mothe.
165.00 173.25(%) -
Coforge
2,055.35 2,127.30(%) -
ICICI Bank
1,608.75 1,616.70(%) -
Black Box
933.85 1,104.30(%) -
Bharti Airtel
2,159.95 2,174.70(%) -
Cipla
1,406.95 1,165.55(%) -
M & M
3,524.50 3,840.00(%) -
IndusInd Bank
924.50 1,077.80(%) -
Max Financial
1,383.90 1,173.40(%) -
HDFC Bank
822.10 1,017.90(%) -
Tube Investments
2,247.35 3,335.00(%) -
Mah. Seamless
497.00 493.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 12579.0
- ISIN : INE873D01024
-
Today’s Low
231.11 -
Today’s High
239.73
-
Open
237.55 -
Perv Close
242.01 -
52W Low
162.19 -
52W High
287.80
Key Indicators
-
P/E(TTM)
268.22
-
Mar.Cap (₹Cr.)
2,151.76
-
Div & Yield %
0.09
-
Book Value(₹)
131.04
-
Debt-Equity Ratio
-3.69
-
AGM Date
19-Nov-2026
-
EPS
0.87
-
P/E Ratio
268.22
Financials Ratios
-
Debt-Equity Ratio
0.47
-
Mar.Cap (₹Cr.)
2,151.76
-
RONW (%)
9.07
-
ROCE (%)
10.76
Score Board
-
Equity (₹ in Cr.)
18.46
-
BV (₹)
131.00
-
Sales( ₹ in Cr.)
1,686.07
-
NP (in Cr.)
-3.05
-
NP Var(%)
68.0
-
Div%
10.0
-
CPS (₹)
11.20
-
EPS (₹)
-0.30
-
Traded Value (₹ in Lakhs)
2,154.25
-
52 Week High
287.80
-
52 Week Low
162.19
-
Price BSE
233.0
-
Price NSE
233.00
-
Market Capital( in Cr.)
2,154.25
-
P/C Ratio
20.70
-
P/E Ratio
-704.30
-
Price Vs.BV
-0.30
-
18-Nov-2026( 09:30)
Hot Pursuit - Indoc... - <p>Indoco Remedies Ltd gained...
-
28-Oct-2026( 10:27)
Results - Announcements - Indoc... - <p>Indoco Remedies Ltd share p...
-
27-Oct-2026( 10:58)
Corporate News - Indoc... - <p>Indoco Remedies Limited ann...
-
14-Oct-2026( 04:23)
Corporate News - Indoc... - <p>Indoco Remedies Limited wil...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,686.07 | 1,518.19 | 1,790.81 | 1,666.69 | 1,539.72 | 1,240.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,686.07 | 1,518.19 | 1,790.81 | 1,666.69 | 1,539.72 | 1,240.30 |
| Other Income | 33.10 | 19.48 | 28.24 | 2.33 | 2.32 | 3.11 |
| Stock Adjustments | -7.20 | 32.04 | 14.70 | -6.55 | 26.30 | 12.13 |
| Total Income | 1,711.97 | 1,569.71 | 1,833.75 | 1,662.47 | 1,568.34 | 1,255.54 |
| EXPENDITURE : | ||||||
| Raw Materials | 493.35 | 475.72 | 561.15 | 514.74 | 483.05 | 366.20 |
| Power and Fuel Cost | 55.44 | 53.45 | 55.31 | 50.61 | 42.78 | 36.89 |
| Employee Cost | 393.63 | 368.74 | 350.55 | 321.15 | 294.95 | 272.88 |
| Other Manufacturing Expenses | 104.33 | 91.60 | 116.72 | 89.70 | 60.66 | 46.07 |
| Selling and Administration Expenses | 387.62 | 387.49 | 407.12 | 340.26 | 293.42 | 258.53 |
| Miscellaneous Expenses | 93.66 | 45.19 | 64.86 | 58.79 | 64.15 | 48.29 |
| Employee Benefit Expenses | 393.63 | 368.74 | 350.55 | 321.15 | 294.95 | 272.88 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,528.03 | 1,422.19 | 1,555.72 | 1,375.25 | 1,239.02 | 1,028.86 |
| Operating Profit | 183.95 | 147.50 | 278.02 | 287.22 | 329.32 | 226.69 |
| Interest | 88.50 | 56.63 | 36.81 | 25.03 | 14.14 | 22.22 |
| Gross Profit | 95.45 | 90.87 | 241.21 | 262.19 | 315.18 | 204.47 |
| Depreciation | 106.90 | 98.25 | 87.98 | 70.60 | 78.95 | 73.12 |
| Profit Before Tax | -11.45 | -7.38 | 153.23 | 191.59 | 236.23 | 131.35 |
| Current Tax | 2.92 | 0.00 | 32.77 | 55.20 | 93.23 | 38.47 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -8.73 | 1.36 | 3.81 | -4.97 | -11.52 | 0.48 |
| Reported Net Profit | -5.63 | -8.74 | 116.64 | 141.36 | 154.52 | 92.39 |
| Extraordinary Items | -2.58 | 0.94 | 8.49 | -0.90 | -0.31 | -0.17 |
| Adjusted Net Profit | -3.05 | -9.68 | 108.15 | 142.26 | 154.83 | 92.56 |
| Adjustment below Net Profit | 1.33 | -4.49 | 0.04 | 1.44 | -5.33 | -0.86 |
| P & L Balance brought forward | 754.44 | 781.49 | 685.55 | 563.48 | 428.11 | 339.35 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1.85 | 13.83 | 20.73 | 20.73 | 13.82 | 2.76 |
| P & L Balance carried down | 748.29 | 754.44 | 781.49 | 685.55 | 563.48 | 428.11 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 75.00 | 112.50 | 112.50 | 75.00 |
| Dividend Per Share(Rs) | 0.20 | 0.20 | 1.50 | 2.25 | 2.25 | 1.50 |
| Earnings Per Share-Unit Curr | -0.61 | -0.95 | 12.65 | 15.34 | 16.77 | 10.03 |
| Earnings Per Share(Adj)-Unit Curr | -0.61 | -0.95 | 12.65 | 15.34 | 16.77 | 10.03 |
| Book Value | 119.08 | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 |
| Book Value(Adj)-Unit Curr | 119.08 | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 |
